Carlsbad-based Invitrogen, a developer of life science technology, said Thursday that it has acquired CellzDirect, a provivder of services used in the testing of new drugs, for approximately $57M in cash. CellzDirect, which is based in Research Triangle Park, North Carolina, provides hepatocyte-based cell products and related services, which is used for predicting the effect of drugs on the liver. Invitrogen said that CellzDirect expects to have revenues of approximately $18M in calendar year 2007.
posted on Friday, January 11, 2008
> Invitrogen Releases Equipment
> Invitrogen Appoints Execs
> Invitrogen Ties Into Procurement
> Invitrogen Invests In Q Therapeutics
> Invitrogen Merges With Applied Biosystems In $6.7B Deal